Author
AbstractI study the effect of health insurance expansions on medical innovation. Practitioner dominated innovation (Roberts, 1988) creates an important role for the incentives in “local” payment systems as drivers of medical technology development. I show that, over the 15 years following Medicare and Medicaid’s passage, U.S.-based patenting shifted towards medical equipment by nearly 1.5 percentage points (50 percent) more than foreign patenting. This did not reflect a more general, U.S.-specific trend towards health-sector innovation; no such increase occurred among pharmaceutical patents, the markets for which were unaffected. Subsequent decreases in cost-sharing for all health spending are also associated with increases in U.S.-based patenting relative to foreign patenting in the relevant areas. Back-of-the-envelope calculations suggest that the dynamic effect of U.S. insurance expansions may account for around 25 percent of global medical-equipment innovation and 15 percent of the rise in U.S. health spending in hospitals, physicians’ offices, and other clinical settings from 1960 to 2010.
Suggested Citation
Jeffrey Clemens, 2012.
"The Effect of U.S. Health Insurance Expansions on Medical Innovation,"
Discussion Papers
11-016, Stanford Institute for Economic Policy Research.
Handle:
RePEc:sip:dpaper:11-016
Download full text from publisher
Other versions of this item:
References listed on IDEAS
- Daron Acemoglu & Amy Finkelstein, 2008.
"Input and Technology Choices in Regulated Industries: Evidence from the Health Care Sector,"
Journal of Political Economy, University of Chicago Press, vol. 116(5), pages 837-880, October.
- G. M.P. Swann, 2009.
"The Economics of Innovation,"
Books,
Edward Elgar Publishing, number 13211.
- Alberto Abadie & Alexis Diamond & Jens Hainmueller, 2007.
"Synthetic Control Methods for Comparative Case Studies: Estimating the Effect of California's Tobacco Control Program,"
NBER Technical Working Papers
0335, National Bureau of Economic Research, Inc.
- Philippe Aghion & Antoine Dechezleprêtre & David Hémous & Ralf Martin & John Van Reenen, 2016.
"Carbon Taxes, Path Dependency, and Directed Technical Change: Evidence from the Auto Industry,"
Journal of Political Economy, University of Chicago Press, vol. 124(1), pages 1-51.
- Philippe Aghion & Antoine Dechezlepr�tre & David Hemous & Ralf Martin & John Van Reenen, 2012.
"Carbon Taxes, Path Dependency and Directed Technical Change: Evidence from the Auto Industry,"
GRI Working Papers
102, Grantham Research Institute on Climate Change and the Environment.
- Philippe Aghion & Antoine Dechezleprêtre & David Hémous & Ralf Martin & John van Reenen, 2016.
"Carbon Taxes, Path Dependency, and Directed Technical Change: Evidence from the Auto Industry,"
Post-Print
halshs-01496920, HAL.
- Philippe Aghion & Antoine Dechezleprêtre & David Hemous & Ralf Martin & John Van Reenen, 2012.
"Carbon Taxes, Path Dependency and Directed Technical Change: Evidence from the Auto Industry,"
NBER Working Papers
18596, National Bureau of Economic Research, Inc.
- Philippe Aghion & Antoine Dechezleprêtre & David Hemous & Ralf Martin & John Van Reenen, 2012.
"Carbon Taxes, Path Dependency and Directed Technical Change: Evidence from the Auto Industry,"
Working Papers
2012.99, Fondazione Eni Enrico Mattei.
- Aghion, Philippe & Dechezlepretre, Antoine & Hemous, David & Martin, Ralf & Van Reenen, John, 2012.
"Carbon taxes, path dependency and directed technical change: evidence from the auto industry,"
LSE Research Online Documents on Economics
48936, London School of Economics and Political Science, LSE Library.
- Philippe Aghion & Antoine Dechezleprêtre & David Hémous & Ralf Martin & John van Reenen, 2016.
"Carbon Taxes, Path Dependency, and Directed Technical Change: Evidence from the Auto Industry,"
PSE-Ecole d'économie de Paris (Postprint)
halshs-01496920, HAL.
- Aghion, Philippe & Dechezlepretre, Antoine & Hemous, David & Martin, Ralf & Van Reenen, John, 2016.
"Carbon taxes, path dependency and directed technical change: evidence from the auto industry,"
LSE Research Online Documents on Economics
62722, London School of Economics and Political Science, LSE Library.
- Aghion, Philippe & Van Reenen, John & Martin, Ralf & Hémous, David & Dechezleprêtre, Antoine, 2012.
"Carbon Taxes, Path Dependency and Directed Technical Change: Evidence from the Auto Industry,"
CEPR Discussion Papers
9267, C.E.P.R. Discussion Papers.
- Aghion, Philippe & Dechezlepretre, Antoine & Hemous, David & Martin, Ralf & Van Reenen, John, 2012.
"Carbon Taxes, Path Dependency and Directed Technical Change: Evidence from the Auto Industry,"
Climate Change and Sustainable Development
143129, Fondazione Eni Enrico Mattei (FEEM).
- Aghion, Philippe & Dechezleprêtre, Antoine & Hemous, David & Martin, Ralf & Van Reenen, John, 2016.
"Carbon Taxes, Path Dependency, and Directed Technical Change: Evidence from the Auto Industry,"
Scholarly Articles
27759048, Harvard University Department of Economics.
- Philippe Aghion & Antoine Dechezleprêtre & David Hemous & Ralf Martin & John Van Reenen, 2012.
"Carbon Taxes, Path Dependency and Directed Technical Change: Evidence from the Auto Industry,"
CEP Discussion Papers
dp1178, Centre for Economic Performance, LSE.
- Freedman, Seth & Lin, Haizhen & Simon, Kosali, 2015.
"Public health insurance expansions and hospital technology adoption,"
Journal of Public Economics, Elsevier, vol. 121(C), pages 117-131.
- Seth Freedman & Haizhen Lin & Kosali Simon, 2012.
"Public Health Insurance Expansions and Hospital Technology Adoption,"
Working Papers
2012-08, Indiana University, Kelley School of Business, Department of Business Economics and Public Policy.
- Seth Freedman & Haizhen Lin & Kosali Simon, 2014.
"Public Health Insurance Expansions and Hospital Technology Adoption,"
NBER Working Papers
20159, National Bureau of Economic Research, Inc.
- Seth Freedman & Haizhen Lin & Kosali Simon, 2014.
"Public Health Insurance Expansions and Hospital Technology Adoption,"
Working Papers
2014-04, Indiana University, Kelley School of Business, Department of Business Economics and Public Policy.
- Finkelstein, Amy & McKnight, Robin, 2008.
"What did Medicare do? The initial impact of Medicare on mortality and out of pocket medical spending,"
Journal of Public Economics, Elsevier, vol. 92(7), pages 1644-1668, July.
- Jeffrey Clemens & Joshua D. Gottlieb, 2014.
"Do Physicians' Financial Incentives Affect Medical Treatment and Patient Health?,"
American Economic Review, American Economic Association, vol. 104(4), pages 1320-1349, April.
- Daron Acemoglu, 1998.
"Why Do New Technologies Complement Skills? Directed Technical Change and Wage Inequality,"
The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 113(4), pages 1055-1089.
- Cutler, David M. & Pozen, Alexis, 2010.
"Medical Spending Differences in the United States and Canada: The Role of Prices, Procedures, and Administrative Expenses,"
Scholarly Articles
5343032, Harvard University Department of Economics.
- Bronwyn H. Hall & Adam B. Jaffe & Manuel Trajtenberg, 2001.
"The NBER Patent Citation Data File: Lessons, Insights and Methodological Tools,"
NBER Working Papers
8498, National Bureau of Economic Research, Inc.
- Hall, B. & Jaffe, A. & Trajtenberg, M., 2001.
"The NBER Patent Citations Data File: Lessons, Insights and Methodological Tools,"
Papers
2001-29, Tel Aviv.
- Hall, Bronwyn & Trajtenberg, Manuel & Jaffe, Adam B, 2001.
"The NBER Patent Citations Data File: Lessons, Insights and Methodological Tools,"
CEPR Discussion Papers
3094, C.E.P.R. Discussion Papers.
- Petra Moser & Alessandra Voena, 2012.
"Compulsory Licensing: Evidence from the Trading with the Enemy Act,"
American Economic Review, American Economic Association, vol. 102(1), pages 396-427, February.
- K. J. Arrow, 1971.
"The Economic Implications of Learning by Doing,"
Palgrave Macmillan Books, in: F. H. Hahn (ed.), Readings in the Theory of Growth, chapter 11, pages 131-149,
Palgrave Macmillan.
- Ernst R. Berndt & Rachel Glennerster & Michael R. Kremer & Jean Lee & Ruth Levine & Georg Weizsäcker & Heidi Williams, 2007.
"Advance market commitments for vaccines against neglected diseases: estimating costs and effectiveness,"
Health Economics, John Wiley & Sons, Ltd., vol. 16(5), pages 491-511, May.
- Cutler, David M, 1995.
"The Incidence of Adverse Medical Outcomes under Prospective Payment,"
Econometrica, Econometric Society, vol. 63(1), pages 29-50, January.
- Margaret E. Blume-Kohout & Neeraj Sood, 2008.
"The Impact of Medicare Part D on Pharmaceutical R&D,"
NBER Working Papers
13857, National Bureau of Economic Research, Inc.
- Amy Finkelstein & Sarah Taubman & Bill Wright & Mira Bernstein & Jonathan Gruber & Joseph P. Newhouse & Heidi Allen & Katherine Baicker, 2012.
"The Oregon Health Insurance Experiment: Evidence from the First Year,"
The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 127(3), pages 1057-1106.
- Finkelstein, Amy, et al., 2011.
"The Oregon Health Insurance Experiment: Evidence from the First Year,"
Working Paper Series
rwp11-040, Harvard University, John F. Kennedy School of Government.
- Amy Finkelstein & Sarah Taubman & Bill Wright & Mira Bernstein & Jonathan Gruber & Joseph P. Newhouse & Heidi Allen & Katherine Baicker & The Oregon Health Study Group, 2011.
"The Oregon Health Insurance Experiment: Evidence from the First Year,"
NBER Working Papers
17190, National Bureau of Economic Research, Inc.
- Abadie, Alberto & Diamond, Alexis & Hainmueller, Jens, 2010.
"Synthetic Control Methods for Comparative Case Studies: Estimating the Effect of California’s Tobacco Control Program,"
Journal of the American Statistical Association, American Statistical Association, vol. 105(490), pages 493-505.
- Daron Acemoglu & Joshua Linn, 2004.
"Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry,"
The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 119(3), pages 1049-1090.
- Anup Malani & Tomas J. Philipson, 2011.
"Can Medical Progress be Sustained? Implications of the Link Between Development and Output Markets,"
NBER Working Papers
17011, National Bureau of Economic Research, Inc.
- Eric Budish & Benjamin N. Roin & Heidi Williams, 2015.
"Do Firms Underinvest in Long-Term Research? Evidence from Cancer Clinical Trials,"
American Economic Review, American Economic Association, vol. 105(7), pages 2044-2085, July.
- Eric Budish & Benjamin Roin & Heidi Williams, 2013.
"Do fixed patent terms distort innovation? Evidence from cancer clinical trials,"
Discussion Papers
13-001, Stanford Institute for Economic Policy Research.
- Amitabh Chandra & Jonathan Skinner, 2012.
"Technology Growth and Expenditure Growth in Health Care,"
Journal of Economic Literature, American Economic Association, vol. 50(3), pages 645-680, September.
- Popp David & Juhl Ted & Johnson Daniel K.N., 2004.
"Time In Purgatory: Examining the Grant Lag for U.S. Patent Applications,"
The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 4(1), pages 1-45, November.
- Mitchell A. Petersen, 2009.
"Estimating Standard Errors in Finance Panel Data Sets: Comparing Approaches,"
The Review of Financial Studies, Society for Financial Studies, vol. 22(1), pages 435-480, January.
- Robert E. Hall & Charles I. Jones, 2007.
"The Value of Life and the Rise in Health Spending,"
The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 122(1), pages 39-72.
- Katherine Baicker & Dana Goldman, 2011.
"Patient Cost-Sharing and Healthcare Spending Growth,"
Journal of Economic Perspectives, American Economic Association, vol. 25(2), pages 47-68, Spring.
- Pierre Dubois & Olivier de Mouzon & Fiona Scott-Morton & Paul Seabright, 2015.
"Market size and pharmaceutical innovation,"
RAND Journal of Economics, RAND Corporation, vol. 46(4), pages 844-871, October.
- Dubois, Pierre & de Mouzon, Olivier & Scott Morton, Fiona & Seabright, Paul, 2011.
"Market Size and Pharmaceutical Innovation,"
IDEI Working Papers
670, Institut d'Économie Industrielle (IDEI), Toulouse, revised Mar 2014.
- Dubois, Pierre & de Mouzon, Olivier & Scott Morton, Fiona & Seabright, Paul, 2011.
"Market Size and Pharmaceutical Innovation,"
TSE Working Papers
11-232, Toulouse School of Economics (TSE), revised Mar 2014.
- Seabright, Paul & Scott Morton, Fiona & Dubois, Pierre & de Mouzon, Olivier, 2011.
"Market Size and Pharmaceutical Innovation,"
CEPR Discussion Papers
8367, C.E.P.R. Discussion Papers.
- Darius Lakdawalla & Neeraj Sood, 2007.
"The Welfare Effects of Public Drug Insurance,"
NBER Working Papers
13501, National Bureau of Economic Research, Inc.
- David Popp & Ted Juhl & Daniel K.N. Johnson, 2003.
"Time in Purgatory: Determinants of the Grant Lag for U.S. Patent Applications,"
NBER Working Papers
9518, National Bureau of Economic Research, Inc.
- Joseph P. Newhouse, 1992.
"Medical Care Costs: How Much Welfare Loss?,"
Journal of Economic Perspectives, American Economic Association, vol. 6(3), pages 3-21, Summer.
- Michael Kremer, 2002.
"Pharmaceuticals and the Developing World,"
Journal of Economic Perspectives, American Economic Association, vol. 16(4), pages 67-90, Fall.
- Manuel Trajtenberg, 1990.
"A Penny for Your Quotes: Patent Citations and the Value of Innovations,"
RAND Journal of Economics, The RAND Corporation, vol. 21(1), pages 172-187, Spring.
- von Hippel, Eric, 1976.
"The dominant role of users in the scientific instrument innovation process,"
Research Policy, Elsevier, vol. 5(3), pages 212-239, July.
- Adam B. Jaffe & Manuel Trajtenberg, 2005.
"Patents, Citations, and Innovations: A Window on the Knowledge Economy,"
MIT Press Books,
The MIT Press,
edition 1, volume 1, number 026260065x, December.
- Alberto Abadie & Javier Gardeazabal, 2003.
"The Economic Costs of Conflict: A Case Study of the Basque Country,"
American Economic Review, American Economic Association, vol. 93(1), pages 113-132, March.
- Glied, Sherry & Zivin, Joshua Graff, 2002.
"How do doctors behave when some (but not all) of their patients are in managed care?,"
Journal of Health Economics, Elsevier, vol. 21(2), pages 337-353, March.
- Jeffrey Clemens & Joshua D. Gottlieb, 2017.
"In the Shadow of a Giant: Medicare’s Influence on Private Physician Payments,"
Journal of Political Economy, University of Chicago Press, vol. 125(1), pages 1-39.
- Petra Moser, 2012.
"Innovation without Patents: Evidence from World's Fairs,"
Journal of Law and Economics, University of Chicago Press, vol. 55(1), pages 43-74.
- Abadie, Alberto & Diamond, Alexis & Hainmueller, Jens, 2011.
"Synth: An R Package for Synthetic Control Methods in Comparative Case Studies,"
Journal of Statistical Software, Foundation for Open Access Statistics, vol. 42(i13).
- Amy Finkelstein, 2004.
"Static and Dynamic Effects of Health Policy: Evidence from the Vaccine Industry,"
The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 119(2), pages 527-564.
- Amitabh Chandra & Douglas O. Staiger, 2007.
"Productivity Spillovers in Health Care: Evidence from the Treatment of Heart Attacks,"
Journal of Political Economy, University of Chicago Press, vol. 115(1), pages 103-140.
- David M. Cutler, 1998.
"Cost Shifting or Cost Cutting? The Incidence of Reductions in Medicare Payments,"
NBER Chapters, in: Tax Policy and the Economy, Volume 12, pages 1-28,
National Bureau of Economic Research, Inc.
- Charles I. Jones, 2016.
"Life and Growth,"
Journal of Political Economy, University of Chicago Press, vol. 124(2), pages 539-578.
- Amy Finkelstein, 2007.
"The Aggregate Effects of Health Insurance: Evidence from the Introduction of Medicare,"
The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 122(1), pages 1-37.
- David Popp, 2002.
"Induced Innovation and Energy Prices,"
American Economic Review, American Economic Association, vol. 92(1), pages 160-180, March.
- Trajtenberg, Manuel, 1989.
"The Welfare Analysis of Product Innovations, with an Application to Computed Tomography Scanners,"
Journal of Political Economy, University of Chicago Press, vol. 97(2), pages 444-479, April.
- Lakdawalla, Darius & Sood, Neeraj, 2009.
"Innovation and the welfare effects of public drug insurance,"
Journal of Public Economics, Elsevier, vol. 93(3-4), pages 541-548, April.
- Weisbrod, Burton A, 1991.
"The Health Care Quadrilemma: An Essay on Technological Change, Insurance, Quality of Care, and Cost Containment,"
Journal of Economic Literature, American Economic Association, vol. 29(2), pages 523-552, June.
Full references (including those not matched with items on IDEAS)
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Massimo Florio & Simona Gamba, 2021.
"Biomed Europa: After the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly,"
Annals of Public and Cooperative Economics, Wiley Blackwell, vol. 92(3), pages 387-409, September.
- Johanna Catherine Maclean & Ioana Popovici & Elisheva Stern, 2015.
"Health Insurance Expansions and Provider Behavior: Evidence from Substance Use Disorder Providers,"
DETU Working Papers
1510, Department of Economics, Temple University.
- Maclean, J. Catherine & Popovici, Ioana & Stern, Elisheva Rachel, 2017.
"Health Insurance Expansions and Provider Behavior: Evidence from Substance Use Disorder Providers,"
IZA Discussion Papers
10478, Institute of Labor Economics (IZA).
- Johanna Catherine Maclean & Ioana Popovici & Elisheva Rachel Stern, 2017.
"Health Insurance Expansions and Provider Behavior: Evidence from Substance Use Disorder Providers,"
NBER Working Papers
23094, National Bureau of Economic Research, Inc.
- Freedman, Seth & Lin, Haizhen & Simon, Kosali, 2015.
"Public health insurance expansions and hospital technology adoption,"
Journal of Public Economics, Elsevier, vol. 121(C), pages 117-131.
- Seth Freedman & Haizhen Lin & Kosali Simon, 2012.
"Public Health Insurance Expansions and Hospital Technology Adoption,"
Working Papers
2012-08, Indiana University, Kelley School of Business, Department of Business Economics and Public Policy.
- Seth Freedman & Haizhen Lin & Kosali Simon, 2014.
"Public Health Insurance Expansions and Hospital Technology Adoption,"
Working Papers
2014-04, Indiana University, Kelley School of Business, Department of Business Economics and Public Policy.
- Seth Freedman & Haizhen Lin & Kosali Simon, 2014.
"Public Health Insurance Expansions and Hospital Technology Adoption,"
NBER Working Papers
20159, National Bureau of Economic Research, Inc.
- Jeffrey Clemens & Stan Veuger, 2015.
"Risks to the Returns to Medical Innovation: The Case of Myriad Genetics,"
NBER Working Papers
21469, National Bureau of Economic Research, Inc.
- Jeffrey Clemens & Stan Veuger, 2017.
"Risks To The Returns To Medical Innovation: The Case Of Myriad Genetics,"
Contemporary Economic Policy, Western Economic Association International, vol. 35(2), pages 345-357, April.
- Jeffrey P. Clemens & Morten Olsen, 2021.
"Medicare and the Rise of American Medical Patenting: The Economics of User-Driven Innovation,"
CESifo Working Paper Series
9008, CESifo.
- Gamba, Simona & Magazzini, Laura & Pertile, Paolo, 2021.
"R&D and market size: Who benefits from orphan drug legislation?,"
Journal of Health Economics, Elsevier, vol. 80(C).
- Clemens, Jeffrey, 2014.
"Implications of Physician Ethics, Billing Norms, and Service Cost Structures for Medicare's Fee Schedule,"
MPRA Paper
73392, University Library of Munich, Germany.
- Bloom, David E. & Kuhn, Michael & Prettner, Klaus, 2018.
"Health and Economic Growth,"
IZA Discussion Papers
11939, Institute of Labor Economics (IZA).
- Jeffrey Clemens & Joshua D. Gottlieb, 2017.
"In the Shadow of a Giant: Medicare’s Influence on Private Physician Payments,"
Journal of Political Economy, University of Chicago Press, vol. 125(1), pages 1-39.
- Jeffrey Clemens & Joshua D. Gottlieb, 2014.
"Do Physicians' Financial Incentives Affect Medical Treatment and Patient Health?,"
American Economic Review, American Economic Association, vol. 104(4), pages 1320-1349, April.
- Jeffrey P. Clemens & Parker Rogers, 2020.
"Demand Shocks, Procurement Policies, and the Nature of Medical Innovation: Evidence from Wartime Prosthetic Device Patents,"
CESifo Working Paper Series
8781, CESifo.
- Dunn, Abe & Shapiro, Adam Hale, 2015.
"Physician payments under health care reform,"
Journal of Health Economics, Elsevier, vol. 39(C), pages 89-105.
- Zhang, Xuan & Nie, Huihua, 2021.
"Public health insurance and pharmaceutical innovation: Evidence from China,"
Journal of Development Economics, Elsevier, vol. 148(C).
- Clayton, Denise Hammock, 2019.
"The Effect of Prescription Drug Coverage on Mortality: Evidence from Medicaid Implementation,"
Journal of Health Economics, Elsevier, vol. 63(C), pages 100-113.
- Charles I. Jones, 2016.
"Life and Growth,"
Journal of Political Economy, University of Chicago Press, vol. 124(2), pages 539-578.
- Galasso, Alberto & Luo, Hong, 2016.
"Tort Reform and Innovation,"
CEPR Discussion Papers
11358, C.E.P.R. Discussion Papers.
- Frankovic, Ivan & Kuhn, Michael, 2018.
"Health insurance, endogenous medical progress, and health expenditure growth,"
ECON WPS - Working Papers in Economic Theory and Policy
01/2018, TU Wien, Institute of Statistics and Mathematical Methods in Economics, Economics Research Unit.
- Lakdawalla, Darius & Malani, Anup & Reif, Julian, 2017.
"The insurance value of medical innovation,"
Journal of Public Economics, Elsevier, vol. 145(C), pages 94-102.
- Kristopher J. Hult & Tomas J. Philipson, 2012.
"Public Liabilities and Health Care Policy,"
NBER Working Papers
18571, National Bureau of Economic Research, Inc.
- Leila Agha & Soomi Kim & Danielle Li, 2020.
"Insurance Design and Pharmaceutical Innovation,"
NBER Working Papers
27563, National Bureau of Economic Research, Inc.
- Chen, Simiao & Kuhn, Michael & Prettner, Klaus & Bloom, David E. & Wang, Chen, 2021.
"Macro-level efficiency of health expenditure: Estimates for 15 major economies,"
Social Science & Medicine, Elsevier, vol. 287(C).
- Alberto Galasso & Hong Luo, 2016.
"Tort Reform and Innovation,"
NBER Working Papers
22712, National Bureau of Economic Research, Inc.
- Amitabh Chandra & Jonathan Holmes & Jonathan Skinner, 2013.
"Is This Time Different? The Slowdown in Healthcare Spending,"
Brookings Papers on Economic Activity, Economic Studies Program, The Brookings Institution, vol. 44(2 (Fall)), pages 261-323.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.
- Jeffrey P. Clemens & Parker Rogers, 2020.
"Demand Shocks, Procurement Policies, and the Nature of Medical Innovation: Evidence from Wartime Prosthetic Device Patents,"
CESifo Working Paper Series
8781, CESifo.
- Frankovic, Ivan & Kuhn, Michael, 2018.
"Health insurance, endogenous medical progress, and health expenditure growth,"
ECON WPS - Working Papers in Economic Theory and Policy
01/2018, TU Wien, Institute of Statistics and Mathematical Methods in Economics, Economics Research Unit.
- Jeffrey P. Clemens & Morten Olsen, 2021.
"Medicare and the Rise of American Medical Patenting: The Economics of User-Driven Innovation,"
CESifo Working Paper Series
9008, CESifo.
- Volker Grossmann, 2021.
"Medical Innovations and Ageing: A Health Economics Perspective,"
CESifo Working Paper Series
9387, CESifo.
- Jeffrey Clemens & Stan Veuger, 2017.
"Risks To The Returns To Medical Innovation: The Case Of Myriad Genetics,"
Contemporary Economic Policy, Western Economic Association International, vol. 35(2), pages 345-357, April.
- Jeffrey Clemens & Joshua D. Gottlieb, 2017.
"In the Shadow of a Giant: Medicare’s Influence on Private Physician Payments,"
Journal of Political Economy, University of Chicago Press, vol. 125(1), pages 1-39.
- Frankovic, Ivan & Kuhn, Michael, 2023.
"Health insurance, endogenous medical progress, health expenditure growth, and welfare,"
Journal of Health Economics, Elsevier, vol. 87(C).
- Jeffrey Clemens & Stan Veuger, 2015.
"Risks to the Returns to Medical Innovation: The Case of Myriad Genetics,"
NBER Working Papers
21469, National Bureau of Economic Research, Inc.
- Dranove, David & Garthwaite, Craig & Heard, Christopher & Wu, Bingxiao, 2022.
"The economics of medical procedure innovation,"
Journal of Health Economics, Elsevier, vol. 81(C).
- Daron Acemoglu & Amy Finkelstein & Matthew J. Notowidigdo, 2013.
"Income and Health Spending: Evidence from Oil Price Shocks,"
The Review of Economics and Statistics, MIT Press, vol. 95(4), pages 1079-1095, October.
- Acemoglu, Daron & Finkelstein, Amy & Notowidigdo, Matthew J., 2009.
"Income and Health Spending: Evidence from Oil Price Shocks,"
CEPR Discussion Papers
7255, C.E.P.R. Discussion Papers.
- Daron Acemoglu & Amy Finkelstein & Matthew J. Notowidigdo, 2009.
"Income and Health Spending: Evidence from Oil Price Shocks,"
NBER Working Papers
14744, National Bureau of Economic Research, Inc.
- Leila Agha & Soomi Kim & Danielle Li, 2020.
"Insurance Design and Pharmaceutical Innovation,"
NBER Working Papers
27563, National Bureau of Economic Research, Inc.
- Jeffrey Clemens & Joshua D. Gottlieb, 2014.
"Do Physicians' Financial Incentives Affect Medical Treatment and Patient Health?,"
American Economic Review, American Economic Association, vol. 104(4), pages 1320-1349, April.
- Amitabh Chandra & Jonathan Skinner, 2012.
"Technology Growth and Expenditure Growth in Health Care,"
Journal of Economic Literature, American Economic Association, vol. 50(3), pages 645-680, September.
- Daron Acemoglu & Amy Finkelstein, 2008.
"Input and Technology Choices in Regulated Industries: Evidence from the Health Care Sector,"
Journal of Political Economy, University of Chicago Press, vol. 116(5), pages 837-880, October.
- Freedman, Seth & Lin, Haizhen & Simon, Kosali, 2015.
"Public health insurance expansions and hospital technology adoption,"
Journal of Public Economics, Elsevier, vol. 121(C), pages 117-131.
- Seth Freedman & Haizhen Lin & Kosali Simon, 2012.
"Public Health Insurance Expansions and Hospital Technology Adoption,"
Working Papers
2012-08, Indiana University, Kelley School of Business, Department of Business Economics and Public Policy.
- Seth Freedman & Haizhen Lin & Kosali Simon, 2014.
"Public Health Insurance Expansions and Hospital Technology Adoption,"
Working Papers
2014-04, Indiana University, Kelley School of Business, Department of Business Economics and Public Policy.
- Seth Freedman & Haizhen Lin & Kosali Simon, 2014.
"Public Health Insurance Expansions and Hospital Technology Adoption,"
NBER Working Papers
20159, National Bureau of Economic Research, Inc.
- Chen, Simiao & Kuhn, Michael & Prettner, Klaus & Bloom, David E. & Wang, Chen, 2021.
"Macro-level efficiency of health expenditure: Estimates for 15 major economies,"
Social Science & Medicine, Elsevier, vol. 287(C).
- Olatunji A. Shobande & Lawrence Ogbeifun & Simplice A. Asongu, 2022.
"Globalisation, technology and global health,"
Working Papers of the African Governance and Development Institute.
22/070, African Governance and Development Institute..
- Bloom, David E. & Kuhn, Michael & Prettner, Klaus, 2018.
"Health and Economic Growth,"
IZA Discussion Papers
11939, Institute of Labor Economics (IZA).
- Aggarwal, Mayank & Chakrabarti, Anindya S. & Chatterjee, Chirantan & Higgins, Matthew J., 2023.
"Research and market structure: Evidence from an antibiotic-resistant pathogenic outbreak,"
Research Policy, Elsevier, vol. 52(1).
- Amitabh Chandra & Jonathan S. Skinner, 2011.
"Technology Growth and Expenditure Growth in Health Care,"
NBER Working Papers
16953, National Bureau of Economic Research, Inc.
More about this item
JEL classification:
- I13 - Health, Education, and Welfare - - Health - - - Health Insurance, Public and Private
- O38 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Government Policy
- O31 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Innovation and Invention: Processes and Incentives
- H51 - Public Economics - - National Government Expenditures and Related Policies - - - Government Expenditures and Health
- I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets
NEP fields
This paper has been announced in the following
NEP Reports:
Statistics
Access and download statistics
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sip:dpaper:11-016. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Anne Shor (email available below). General contact details of provider: https://edirc.repec.org/data/cestaus.html .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.